Skip to main content

Cornell University

Fischbach Lab

We apply engineering principles to understand how tissue microenvironments influence cancer initiation, development, and therapy response.

Regan Stephenson

Regan Stephenson
Regan Stephenson

My current projects use 3D in vitro models to understand the implications of macrophages on immunotherapy effectiveness for treating cancer. In particular, I am interested in harnessing tumor-associated macrophages to augment standard cancer treatment regimens.

I received by B.S. in Biomedical Engineering from the University of Utah in 2016. My research focus was on developing decellularized bone matrices for hematopoietic stem cell differentiation. After undergrad, I came to Cornell and did my M.S. in Biomedical Engineering with Ankur Singh on microfluidic-produced hydrogel models of B cell lymphoma to study tumor heterogeneity. My previous work has driven my passion for immunoengineering and immunotherapy targets for cancer culminating in my current project in the Fischbach group as I pursue a PhD in Biomedical Engineering.